PrimeX News

S&P 500 and Dow Jones Forecast: Stocks Face Inflation Risk Despite Trade Relief
Sat, 27 Jun 2026 09:37:25 GMT
Nokia (NOK) Price Forecast: Head and Shoulders Signals Deeper Pullback
Fri, 26 Jun 2026 20:59:36 GMT
Gold (XAU/USD) Price Forecast: Trendline Break Signals Bearish Extension
Fri, 26 Jun 2026 20:46:30 GMT
Natural Gas Price Forecast: Can Bulls Break $3.44 Ceiling?
Fri, 26 Jun 2026 20:34:11 GMT
Gold’s Summer Pullback May Be the Last Great Buying Opportunity Before New 2026 Highs
Fri, 26 Jun 2026 19:55:29 GMT
Oil News: Crude Oil Futures Sink Below 200-Day Average on Oil Demand Fears
Fri, 26 Jun 2026 19:48:58 GMT

From Currencies to Commodities: Leveraging Gold Ratios in Trading
Thu, 25 Jun 2026 12:59:13 GMT
First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

CNTX

Context Therapeutics Inc. Common Stock

0.58

USD

+0.02

+3.57%

Jun 26, 16:00 UTC -4

Closed

exchange

After-Market

0.58

+0.01

+0.86%

CNTX News & Forecasts

featured

Small Biotech Context Therapeutics Reports 29% Response Rate In Ovarian Cancer Study

Advertisement

Advertisement

Advertisement